Evo 750mg

Tablet
Levofloxacin (Oral)
Beximco Pharmaceuticals Ltd

Other Strength:
- LEVOPA 100mg+10mg
- Levoxin 750mg
- Levocar® 330mg
- Levostar® 1mg
- Trevox 500mg
- Trevox 750mg
- Levobac 500mg
- Levobac 750mg
- Brodil Levo 1mg
- Brodil Levo 2mg
- Levonix 500mg
- Nevola 100mg
- Nevola 50mg
- Levoday 500mg
- Levocet 5mg
- Levo 500mg
- Devoid 25mg+50mg
- Evo 0.05%
- Evo 500mg/100ml
- Evo TS 1.5%
- Levoxin 125mg/5ml
- Levoxin 500mg/100ml
- Levoxin 0.5%
- Levoxin TS 1.5%
- Trevox 500mg/100ml
- Revofer 500mg/10ml
- Revofer 750mg/15ml
- Levostar 2mg
- Levostar 1gm/5ml
- Levopa 250mg+25mg
- Levoking 125mg/5ml
- Levoking 500mg

Alternative:
- Levoxin 750mg
- Trevox 750mg
- Levobac 750mg
- Leflox 750mg



Evo
Description
Levofloxacin is a synthetic, broad-spectrum antibacterial agent. Chemically Levofloxacin is a chiral fluorinated carboxyquinolone.

Indications

Acute maxillary sinusitis due to Streptococcus pneumoniae, Haemophilus influenzae,or Moraxella catarrhalis.
Acute bacterial exacerbation of chronic bronchitis due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae or Moraxella catarrhalis.
Nosocomial pneumonia due to methicillin-susceptible Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, or Streptococcus pneumoniae.
Community acquired pneumonia due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila or Mycoplasma pneumoniae.
Uncomplicated urinary tract infections due to E. coli, Klebsiella pneumoniae or Staphylococcus saprophyticus.
Complicated urinary tract infections due to Enterococcus faecalis, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, or Pseudomonas aeruginosa.
Acute pyelonephritis caused by E. coli.
Uncomplicated & complicated skin and skin structure infections including abscesses, cellulitis, furuncles, impetigo, and pyoderma, wound infections, due to Staphylococcus aureus, Streptococcus pyogenes, Proteus mirabilis or Enterococcus faecalis.
Chronic bacterial prostatitis due to Escherichia coli, Enterococcus faecalis, or Staphylococcus epidermidis.

Dosage and Administration
Acute sinusitis: 500 mg once daily for 10-14 days
Acute sinusitis: 750 mg once daily for 5 days
Exacerbation of chronic bronchitis: 500 mg once daily for 7 days
Community acquired pneumonia: 500 mg once daily for 7-14 days
Community acquired pneumonia: 750 mg once daily for 5 days
Nosocomial pneumonia: 750 mg once daily for 7-14 days
Uncomplicated urinary tract infections: 250 mg once daily for 3 days
Complicated urinary tract infections and acute pyelonephritis: 250 mg once daily for 10 days
Complicated urinary tract infections and acute pyelonephritis: 750 mg once daily for 5 days
Uncomplicated skin and skin structure infections: 500 mg once daily for 7-10 days
Complicated skin and skin structure infections: 750 mg once daily for 7-14 days
Chronic bacterial prostatitis: 500 mg once daily for 28 days

Contraindication
Levofloxacin is contraindicated in patients with a history of hypersensitivity to Levofloxacin, quinolone antimicrobial agents, or any other components of this product.

Precautions
The following measures should be taken during administration of Levofloxacin:
While taking Levofloxacin adequate amount of water should be drunk to avoid risk of crystalluria.
Dose adjustment should be exercised during Levofloxacin ingestion in presence of renal insufficiency & hepatic insufficiency.

Side Effects
Levofloxacin is generally well tolerated. However, a few side effects can usually be seen. Side effects include: nausea, vomiting, diarrhoea, abdominal pain, flatulence and rare occurrence of phototoxicity (0.1%). Side effects that may be seen very rarely include tremors, depression, anxiety, confusion etc.

Use in Pregnancy & Lactation
Levofloxacin is not recommended for use during pregnancy or nursing, as the effects on the unborn child or nursing infant are unknown.
Use in Children
From clinical studies, it is evident that Levofloxacin can be used in children aged as low as 6 months.
The usual dose for children in community acquired pneumonia (CAP) is Children aged 6 months to less than 5 years: 10 mg/kg b.i.d. (up to 500 mg per day) for 10 days.
Children aged 5 years to 16 years: 10 mg/kg q.d. (up to 500 mg per day) for 10 days.
The usual dose for children in recurrent or persistent Acute Otitis Media (AOM) is Children aged 6 months to less than 5 years: 10 mg/kg per day (maximum dose: 500 mg/day) given twice daily for 10 days.

Drug Interactions
Antacids, Iron and Absorbents - reduce absorption of Levofloxacin
NSAIDs - may increase risk of CNS stimulation
Warfarin - may increase the risk of bleeding.

Overdosage
Levofloxacin exhibits a low potential for acute toxicity. However, in the events of an acute overdosage, the stomach should be emptied. The patients should be kept under observation and appropriate hydration should be maintained.

Pharmaceutical Precaution and Storage condition
Store in a cool & dry place, protected from light. Keep out of the reach of children.

Commercial Pack
Evo® 250 Tablet: Box containing 30 tablets in 3x10’s blister strips. Each film coated tablet contains Levofloxacin Hemihydrate USP equivalent to Levofloxacin 250 mg.
Evo® 500 Tablet: Box containing 20 tablets in 2x10’s blister strips. Each film coated tablet contains Levofloxacin Hemihydrate USP equivalent to Levofloxacin 500 mg.
Evo® 750 Tablet: Box containing 10 tablets in 1x10’s blister strip. Each film coated tablet contains Levofloxacin Hemihydrate USP equivalent to Levofloxacin 750 mg.
Evo® Oral Solution: Bottle contains 100 ml oral solution. Each 5 ml contains Levofloxacin Hemihydrate USP equivalent to Levofloxacin 125mg.




এই পাতাটি ৩০৬ বার দেখা হয়েছে